Human immunodeficiency virus and the central nervous system.

Area of Science:

• Neuroscience
• Infectious Diseases
• Immunology

Background:

• Neurological diseases are common complications of Human Immunodeficiency Virus type 1 (HIV-1) infection.
• AIDS dementia complex, characterized by cognitive and motor impairment, is a recognized neurological syndrome associated with HIV-1.
• The exact cause of this neurological syndrome remains uncertain, with limited productive HIV-1 infection observed in the brain.

Purpose of the Study:

• To review clinical and laboratory studies on HIV-1-associated neurological disease.
• To explore potential mechanisms of brain injury in the context of HIV-1 infection.
• To describe models investigating the interaction of HIV-1 and immune responses in causing brain damage.

Main Methods:

• Review of existing clinical and laboratory research findings.
• Analysis of studies focusing on HIV-1's interaction with the central nervous system.
• Development and description of theoretical models for HIV-1-induced neurotoxicity.

Main Results:

• Limited productive HIV-1 infection in brain cells suggests indirect injury mechanisms.
• Macrophages and microglia are the primary cells infected in the brain, not neuroectodermal cells.
• Speculation centers on virus- or cell-coded neurotoxins as mediators of brain injury.

Conclusions:

• Indirect mechanisms, potentially involving neurotoxins, are likely responsible for HIV-1-associated neurological damage.
• Understanding the interaction between HIV-1 and immune responses is crucial for explaining brain injury.
• Further research into these indirect pathways is needed to clarify the pathogenesis of AIDS dementia complex.